These results were also confirmed in other mouse models of AD (e.g., APP/PS1 and 3 × Tg-AD mice), where reduced peripheral glucose tolerance occurs prior to AD-related neuropathology or cognitive decline [57,58,59,60]. The gene discussed is PSEN1; the disease is Alzheimer disease.